Recent Press Releases & News
ODTX earnings at a glance
Odyssey Therapeutics, Inc. (ODTX) is scheduled to report earnings on Wednesday, November 4, 2026 — in 11 days. Analysts expect earnings per share of -$1.20. Over its last 2 reports the stock rose the next day 2 times and fell 0, moving ±6.6% on average; after the most recent report on Aug 4, 2026 it moved +10.1%. ODTX beat the consensus EPS estimate in 0 of its last 2 reported quarters. The share price of $19.60 sits in the middle of its 52-week range.
Overview
Earnings trends
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Aug 4, 2026 | 8K 2026-08-04 | $-1.26 | $-0.83 | -51.8% | — | +10.1% | earnings |
| Wed Jun 17, 2026 | 8K 2026-06-17 | $-6.77 | $-1.31 | -416.8% | — | +3.2% | earnings |
| Tue Mar 31, 2026 | Mar 2026 | $-6.77 | — | — | — | — | financials |
| Mon Jun 30, 2025 | Jun 2025 | $-29.54 | — | — | — | — | financials |
| Mon Mar 31, 2025 | Mar 2025 | $-39.37 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Wed Nov 4, 2026 | Sep/2026 | OTHER | -$1.20 | — |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | — | $959,000 | $2M |
| Cost of revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | $-55M | $-40M | — | $-42M | $-39M |
| Net income | $-53M | $-38M | — | $-41M | $-38M |
| EPS (diluted) | $-1.74 | $-6.77 | — | $-29.54 | $-39.37 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Cash & equivalents | $82M | $36M | $42M | $163M | $55M |
| Inventory | — | — | — | — | — |
| Total current assets | $321M | $185M | $191M | — | — |
| Total assets | $484M | $229M | $270M | — | — |
| Long-term debt | — | — | — | — | — |
| Total liabilities | $63M | $49M | $55M | — | — |
| Total equity | $421M | $-524M | $-488M | $-436M | $-417M |
Implied volatility — last 90 days
No IV snapshots yet for ODTX.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.
ODTX earnings FAQ
When is ODTX's next earnings date?
Odyssey Therapeutics, Inc. is expected to report on November 4, 2026.
How does ODTX stock usually react to earnings?
Across the last 2 reports the average next-day move was ±6.6%, up 2 times and down 0 times.
What EPS are analysts expecting from Odyssey Therapeutics, Inc.?
The consensus estimate is -$1.20 per share.